All Stories

  1. Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole

    Article • Pharmaceutics, March 2023, MDPI AG

    Dr kushal shah

  2. Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective

    Article • Clinical Pharmacology & Therapeutics, December 2021, Wiley

    Dr kushal shah

  3. Age-Related Changes in Pediatric Physiology: Quantitative Analysis of Organ Weights and Blood Flows

    Article • The AAPS Journal, March 2021, Springer Science + Business Media

    Dr kushal shah

  4. Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor

    Article • Pulmonary Therapy, July 2020, Springer Science + Business Media

    Dr kushal shah

  5. Using PBPK Modeling to Predict Drug Exposure and Support Dosage Adjustments in Patients With Renal Impairment: An Example with Lamivudine

    Article • Current Drug Discovery Technologies, July 2020, Bentham Science Publishers

    Dr kushal shah, David Taft

  6. Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment

    Article • Open Forum Infectious Diseases, September 2018, Oxford University Press (OUP)

    Dr kushal shah

  7. Toxicity study and analgesic activity of Gmelina arborea extract and its fractions

    Article • Journal of Natural Pharmaceuticals, January 2013, Medknow

    Dr kushal shah